CYTO365 Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.09M
- Investors
-
4
CYTO365 General Information
Description
Manufacturer of intravenous inlets intended to provide an extra layer of security for the administration of drugs. The company offers patented luer inlets with automatic flushing with a flushing fluid that is always available, to separate drugs from mixing and rinsing the tube further down the line, providing clients with inlets to separate drugs from mixing during infusion therapy.
Contact Information
Website
www.cyto365.comCorporate Office
- Kastellgatan 4
- 254 66 Helsingborg
- Sweden
Corporate Office
- Kastellgatan 4
- 254 66 Helsingborg
- Sweden
CYTO365 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 12-Dec-2023 | $1.09M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 01-Nov-2022 | Completed | Generating Revenue | |||
| 2. Grant | 05-Oct-2022 | $1.92M | $530K | Completed | Generating Revenue | |
| 1. Later Stage VC | 31-Dec-2019 | $530K | $530K | Completed | Generating Revenue |
CYTO365 Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CYTO365 Patents
CYTO365 Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4015030-A1 | An improved tactical feel for a multilevel stopcock | Active | 18-Dec-2020 | ||
| EP-4015030-B1 | An improved tactical feel for a multilevel stopcock | Active | 18-Dec-2020 | ||
| EP-4015030-C0 | An improved tactical feel for a multilevel stopcock | Active | 18-Dec-2020 | ||
| ES-3035994-T3 | An improved tactical feel for a multilevel stopcock | Active | 18-Dec-2020 | ||
| AU-2021295867-A1 | A closed-system type female connector, a method for manufacture, and a stopcock having such female connectors | Pending | 24-Jun-2020 | A61M39/22 |
CYTO365 Signals
CYTO365 Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Life Science Invest | Angel Group | Minority | ||
| Svanberg & Co Invest | PE/Buyout | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Horizon Europe | Not-For-Profit Venture Capital |
CYTO365 FAQs
-
When was CYTO365 founded?
CYTO365 was founded in 2013.
-
Where is CYTO365 headquartered?
CYTO365 is headquartered in Helsingborg, Sweden.
-
What is the size of CYTO365?
CYTO365 has 10 total employees.
-
What industry is CYTO365 in?
CYTO365’s primary industry is Medical Supplies.
-
Is CYTO365 a private or public company?
CYTO365 is a Private company.
-
What is CYTO365’s current revenue?
The current revenue for CYTO365 is .
-
How much funding has CYTO365 raised over time?
CYTO365 has raised $3.08M.
-
Who are CYTO365’s investors?
Life Science Invest, Svanberg & Co Invest, European Innovation Council, and Horizon Europe have invested in CYTO365.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process